| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881141 | The Annals of Thoracic Surgery | 2007 | 11 Pages |
Abstract
Goal-directed therapy with Svo2 as an indicator of systemic oxygen delivery is associated with excellent early survival and a low incidence of organ failure after S1P. Inability to optimize Svo2 in the early postoperative period is associated with an increased risk of organ failure, ECMO, and death.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
James S. MD, Nancy S. MD, Kathleen A. BSN, Michael E. MD, Luke J. MD, Ndidiamaka L. MD, Stuart MD, S. Bert MD, George M. MD,